|
 "We are discussing the Moderna COVID-19 vaccine on Friday...," WHO
spokesman Christian Lindmeier said in reply to a query. A decision
on the U.S. drugmaker's vaccine, now being evaluated under the
abridged procedure on the basis of prior review by the European
Medicines Agency, was expected in one to four days after that,
Lindmeier said.
So far COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson &
Johnson have received WHO approval, which is a signal to national
regulatory authorities on a product's safety and efficacy.
The WHO committee of technical experts were on Monday reviewing the
COVID-19 vaccine of Chinese drugmaker Sinopharm and is due to review
the Sinovac product at its next meeting on May 3, according to the
WHO.
[to top of second column] |
Stephane Bancel, Moderna CEO, told an event last Friday that it was
on track to make up to 1 billion doses of its COVID-19 vaccine this
year and 1.4 billion next year.
"We're in the final stretch to get an agreement with COVAX," Bancel
said, referring to the vaccine-sharing facility run by the GAVI
Vaccine Alliance and WHO to bring doses to lower income countries.
(Reporting by Stephanie Nebehay; editing by Emma Farge and Mark
Heinrich)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content |
